IRMD Iradimed Corp

IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th

IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th
EN
08/10/2020

Underlying

IRMDIradimed Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Iradimed Corp

 PRESS RELEASE
Free
IRMD IRADIMED CORP

IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders ...

IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026 Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible medical devices, today announced its selection to TIME's prestigious list of America's Growth Leaders for 2026. This marks the Company's recognition among the top U.S. companies demonstrating outstanding growth, as determined by TIME and Statista. The ranking eva...

November 10, 2025 1 EN
Free Trial
IRMD IRADIMED CORP

Iradimed Corp: 1 director

A director at Iradimed Corp sold 5,000 shares at 82.643USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

11/04/25 November 4, 2025 1 EN
 PRESS RELEASE
Free
IRMD IRADIMED CORP

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Resul...

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024.Reports record GAAP diluted EPS of $0.43 and non-GAAP diluted EPS of $0.47 for the third quarter of 2025, which are increases of 8% and 9%, respectively, compared to the same period in 2024.Raises full-year guidance to revenue of $82.5 million to $83.5 million and GAAP diluted EPS to $1...

November 3, 2025 1 EN
 PRESS RELEASE
Free
IRMD IRADIMED CORP

IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results C...

IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025 ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on Monday, November 3, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a d...

October 27, 2025 1 EN
 PRESS RELEASE
Free
IRMD IRADIMED CORP

IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires...

IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed” or the “Company”) (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”)-compatible patient monitoring and infusion systems, today announced a Board of Directors (the “Board”) transition. Anthony Vuoto has retired from his position as a director, effective August 27, 2025, after deciding it is time to step away following many years of dedicated service. Effective...

September 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch